by Mark G. Taylor, M.S.
Italian researchers found that men who took green tea catechins for one year reduced their risk of developing prostate cancer. In the study, only one of 32 men at high risk of developing prostate cancer were diagnosed with the disease, while nine of 30 in a control group did. They found epigallocatechin gallate (EGCG) targeted prostate cancer cells for death, without damaging benign controls.
